Live Breaking News & Updates on Julie Silber

Stay updated with breaking news from Julie silber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Herantis Pharma Oyj: Managers' Transactions - Tone Kvåle

Herantis Pharma Plc

Company release 9 June 2023 at 14:16 EEST

Herantis Pharma Oyj - Managers Transactions

Person subject to the notification. | June 9, 2023 ....

Julie Silber , Herantis Pharma Oyj , Gabriela Urquilla , Herantis Pharma Plc , Ub Securities Ltd , Herantis Pharma , Pharma Oyj , Chief Financial , Herantis Pharma Oyj Stock Exchange , Press Release , He Hrtis Fi4000087861 ,

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

/PRNewswire/ Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of the patient enrollment for the 600 mg dose cohort from. ....

Julie Silber , Aptevo Therapeutics Inc , Shanghai Henlius Biotech Inc , Orion Corporation , Biotheus Inc , Nasdaq Stockholm , Shanghai Henlius Biotech , Alligator Bioscience ,

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Julie Silber , Aptevo Therapeutics Inc , Shanghai Henlius Biotech Inc , Data Review Committee , Orion Corporation , Biotheus Inc , Alligator Bioscience , Nasdaq Stockholm , Investor Relationsphone , Shanghai Henlius Biotech , Bioscience Announces , Successful Completion ,

Alligator Bioscience AB: Year End report January-December 2021

STOCKHOLM, Feb. 11, 2022 /PRNewswire/ OPTIMIZE-1 Phase II - On Track and Moving Forward "During the fourth quarter 2021, Alligator reached several key milestones in our pre-clinical ....

Zuid Holland , United Kingdom , Julie Silber , Marie Svensson , Aptevo Therapeutics Inc , Shanghai Henlius Biotech Inc , Macrogenics Inc , Erasmus Mc University Medical Center Rotterdam , Abclon Inc , Orion Corporation , Biotheus Inc , Shanghai Henlius Biotech , Medical Center Rotterdam , Aptevo Therapeutics , Rights Issue , Alligator Bioscience , Swedish Securities Markets , Nasdaq Stockholm , Year End ,

Alligator Bioscience AB: Year End report January-December 2021

/PRNewswire/ OPTIMIZE-1 Phase II - On Track and Moving Forward "During the fourth quarter 2021, Alligator reached several key milestones in our. ....

Zuid Holland , United Kingdom , Julie Silber , Marie Svensson , Aptevo Therapeutics Inc , Shanghai Henlius Biotech Inc , Macrogenics Inc , Erasmus Mc University Medical Center Rotterdam , Abclon Inc , Orion Corporation , Biotheus Inc , Shanghai Henlius Biotech , Medical Center Rotterdam , Aptevo Therapeutics , Rights Issue , Alligator Bioscience , Swedish Securities Markets , Nasdaq Stockholm , Health Care Amp Hospitals , Biotechnology , Pharmaceuticals , Medical Pharmaceuticals , Accounting News Amp Issues ,